In Brief This Week: Cancer Genetics; NeoGenomics; BioConsortia; StartX-QB3 Labs; Proteocyte Diagnostics | GenomeWeb

NEW YORK (GenomeWeb) – Cancer Genetics this week said that three of its tests have been included in the National Institutes of Health's Genetic Testing Registry, a searchable online registry of genetic tests. The company's tests now in the registry are FHACT, a FISH-based HPV-associated cancer test; UroGenRA-Kidney, a CGH microarray test for diagnosing and subtyping renal cell carcinoma; and MatBA, a panel for mature B-cell neoplasms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.